Navigation Links
Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
Date:7/23/2008

rties, and our dependence on intellectual property. Further information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission, which are available at http://www.sec.gov.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
4. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
5. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
8. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
9. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
10. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
11. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...Newswire-FirstCall/ -- BioForm Medical,Inc. (Nasd...cal study of,Polidocanol, conducted in Germany by ...LER & Co. GmbH (Kreussler), successfully met the s...A as part of a New Drug Application,(NDA) process....Efficacy and safety of,Aethoxysklerol compared to ...
(Date:9/4/2008)...cian-Gynecologists States UFE Meets Level,A Eviden... Interventional,Radiology Treatment Is Safe, Effec...FAX, Va., Sept. 4 /PRNewswire-USNewswire/ -- The S...anization of nearly 4,500 doctors,scientists and ... health,care through minimally invasive treatment ...
(Date:9/4/2008)... 4 /- Axentis Pharma AG has,initiated...nd tolerability,of a new therapeutic formulation f...cystic fibrosis patients. The new formulation allo...d directly to the site of,infection. The forthcomi...erent doses of the new drug. Initial results are e...
(Date:9/4/2008)...ntification for Targeted Therapies Th...NTINGTON BEACH, Calif., and AMSTERDAM, Netherlands...in molecular cancer diagnostics,today announced t... that,allows physicians to quantitatively determin...tor (ER), progesterone receptor (PR) and Human Epi...
Breaking Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2MIT sculpts 3 D particles with light 1433 1MIT sculpts 3 D particles with light 1433 2Best treatment identified to reduce deadly Staph infections 1431 1Best treatment identified to reduce deadly Staph infections 1431 2Best treatment identified to reduce deadly Staph infections 1431 3Germ Fighting Inhaler Could Fend Off Bioterror Agents 7427 1Germ Fighting Inhaler Could Fend Off Bioterror Agents 7427 2Germ Fighting Inhaler Could Fend Off Bioterror Agents 7427 3Present day species of piranha result from a marine incursion into the Amazon Basin 1430 1Present day species of piranha result from a marine incursion into the Amazon Basin 1430 2Present day species of piranha result from a marine incursion into the Amazon Basin 1430 3
...NGTON, May 21, 2007 /PRNewswire/ -- A new study,de...lubiprostone),given 8 mcg twice a day, may improv...wel syndrome with constipation (IBS-C). These,resu...Disease Week,2007, the largest annual internationa...this study, patients receiving lubiprostone were n...
... being presented today at Digestive Disease Week -...icrobia today,announced the presentation of data f...ed colonic transit and improved bowel function,in ...bowel syndrome,(IBS-C). These data also showed lin...f adverse events. Linaclotide is a first-in-class,...
Other Medicine Technology:New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 2New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 3New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 4New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 5New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 6Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ine survey of more than 21,100 consumers in 38 mar...arly check food packaging and labeling for fat con... calorie and sugar content. The consumers were as...ng, when they would check nutritional information ...
...nvestigating the mysterious death of a woman whose...lood oozed from her ears in an ordeal that started... Reeling from shock and disbelief, the family of J...answers. Officials have classified the case as an ...
...bia led by Dianne Gibb reported that administratin...children reduced fatalities by more than 40% over ...e secondary complications and infections in childr...This affordable treatment was successful in spite ...
...nature that we want to know answers to everything....t our own self. How often have we questioned the ...he answers just do not come. Researchers in a brea...mystery surrounding heart failure. They found that...
Other Medicine News:
...atory system for pH and temperature measurements. ... when used with a temperature probe (ATC) or a 3-i...int calibration with Auto-Find automatic buffer re...0.01 and 12.45) and Auto-Read for locking onto sta...
...atory system for pH and temperature measurements. ... when used with a temperature probe (ATC) or a 3-i...int calibration with Auto-Find automatic buffer re...0.01 and 12.45) and Auto-Read for locking onto sta...
...atory system for pH and temperature measurements. ... when used with a temperature probe (ATC) or a 3-i...int calibration with Auto-Find automatic buffer re...0.01 and 12.45) and Auto-Read for locking onto sta...
...tional high-end microplate reader with outstanding... modes., Fluorescence Intensity - FRET , Fluores... HTRF, AlphaScreen , Luminescence , , , PHERAst...der with fastest read times. The ultimate solution...
Medicine Products: